Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury

Brain Research

Volumn 1134, Issue 1, 2007, Pages 171-179

  Yan, Hong Qu ^a   Ma, Xiecheng ^a   Chen, Xiangbai ^a   Li, Youming ^a   Shao, Lifang ^b   Dixon, C Edward ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Immunohistochemistry; Nigrostriatal; Rat; Traumatic brain injury (TBI); Tyrosine hydroxylase (TH); Western blot

Indexed keywords

BRAIN ENZYME; TYROSINE 3 MONOOXYGENASE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; HOMOGENATE; IMMUNOHISTOCHEMISTRY; MALE; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SUBSTANTIA NIGRA; TRAUMATIC BRAIN INJURY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; COGNITION DISORDERS; CORPUS STRIATUM; DOPAMINE; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MALE; NEURAL PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 33846355347     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.11.087     Document Type: Article

References (69)

1. Anden N.E., Carlsson A., Dahlstroem A., Fuxe K., Hillarp N.A., and Larsson K. Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci. 3 (1964) 523-530
2. Backman L., Robins-Wahlin T.B., Lundin A., Ginovart N., and Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 120 (1997) 2207-2217
3. Bankiewicz K.S., Plunkett R.J., Jacobowitz D.M., Porrino L., di Porzio U., London W.T., Kopin I.J., and Oldfield E.H. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J. Neurosurg. 72 (1990) 231-244
4. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., and Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20 (1973) 415-455
5. Bertler A., and Rosengren E. Occurrence and distribution of catecholamines in brain. Acta Physiol. Scand. 47 (1959) 350-361
6. Blanchard V., Chritin M., Vyas S., Savasta M., Feuerstein C., Agid Y., Javoy-Agid F., and Raisman-Vozari R. Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J. Neurochem. 64 (1995) 1669-1679
7. Blanchard V., Anglade P., Dziewczapolski G., Savasta M., Agid Y., and Raisman-Vozari R. Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res. 709 (1996) 319-325
8. Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11 (1959) 490-493
9. Dietrich W.D., Alonso O., Busto R., Prado R., Zhao W., Dewanjee M.K., and Ginsberg M.D. Posttraumatic cerebral ischemia after fluid percussion brain injury: an autoradiographic and histopathological study in rats. Neurosurgery 43 (1998) 585-593
10. Ding Y., Yao B., Lai Q., and McAllister J.P. Impaired motor learning and diffuse axonal damage in motor and visual systems of the rat following traumatic brain injury. Neurol. Res. 23 (2001) 193-202
11. Divac I., Rosvold H.E., and Szwarcbart M.K. Behavioral effects of selective ablation of the caudate nucleus. J. Comp. Physiol. Psychol. 63 (1967) 184-190
12. Dixon C.E., Clifton G.L., Lighthall J.W., Yaghmai A.A., and Hayes R.L. A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39 (1991) 253-262
13. Doder M., Jahanshahi M., Turjanski N., Moseley I.F., and Lees A.J. Parkinson's syndrome after closed head injury: a single case report. J. Neurol. Neurosurg. Psychiatry 66 (1999) 380-385
14. Donnemiller E., Brenneis C., Wissel J., Scherfler C., Poewe W., Riccabona G., and Wenning G.K. Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Eur. J. Nucl. Med. 27 (2000) 1410-1414
15. Dravid A., Jaton A.L., Enz A., and Frei P. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra. Brain Res. 311 (1984) 361-365
16. Dunn-Meynell A.A., and Levin B.E. Histological markers of neuronal, axonal and astrocytic changes after lateral rigid impact traumatic brain injury. Brain Res. 761 (1997) 25-41
17. Dunn-Meynell B., Pan S., and Levin B.E. Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 h. Brain Res. 660 (1994) 88-95
18. Fiandaca M.S., Kordower J.H., Hansen J.T., Jiao S.S., and Gash D.M. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration. Exp. Neurol. 102 (1988) 76-91
19. Friedman J.H. Progressive parkinsonism in boxers. South Med. J. 82 (1989) 543-546
20. Fritschy J.M., and Grzanna R. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain. J. Comp. Neurol. 321 (1992) 421-441
21. Gilad G.M., and Reis D.J. Collateral sprouting in central mesolimbic dopamine neurons: biochemical and immunocytochemical evidence of changes in the activity and distribution of tyrosine hydroxylase in terminal fields and in cell bodies of A10 neurons. Brain Res. 160 (1979) 17-26
22. Goldstein L.B. Neuropharmacology of TBI-induced plasticity. Brain Inj. 17 (2003) 685-694
23. Guterman A., and Smith R.W. Neurological sequelae of boxing. Sports Med. 4 (1987) 194-210
24. Hirsch E.C., Duyckaerts C., Javoy-Agid F., Hauw J.J., and Agid Y. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?. Ann. Neurol. 27 (1990) 676-682
25. Hokfelt T., and Ungerstedt U. Electron and fluorescence microscopical studies on the nucleus caudatus putamen of the rat after unilateral lesions of ascending nigro-neostriatal dopamine neurons. Acta Physiol. Scand. 76 (1969) 415-426
26. Hokfelt T., Johansson O., Fuxe K., Goldstein M., and Park D. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. I. Tyrosine hydroxylase in the mes- and diencephalon. Med. Biol. 54 (1976) 427-453
27. Hokfelt T., Johansson O., Fuxe K., Goldstein M., and Park D. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain II. Tyrosine hydroxylase in the telencephalon. Med. Biol. 55 (1977) 21-40
28. Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv. Neurol. 60 (1993) 140-147
29. Howells D.W., Donnan G.A., Wong J.Y., Kaczmarczyk S.J., Chilcho P.J., Fabinyi G.C., and Mendelsohn F.A. Surgical damage stimulates proliferation of dopamine uptake sites in normal mouse brain. Brain Res. 622 (1993) 285-288
30. Jaeger C.B., Joh T.H., and Reis D.J. The effect of forebrain lesions in the neonatal rat: survival of midbrain dopaminergic neurons and the crossed nigrostriatal projection. J. Comp. Neurol. 218 (1983) 74-90
31. Joh T.H., and Reis D.J. Different forms of tyrosine hydroxylase in central dopaminergic and noradrenergic neurons and sympathetic ganglia. Brain Res. 85 (1975) 146-151
32. Joyce J.N., Smutzer G., Whitty C.J., Myers A., and Bannon M.J. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Mov. Disord. 12 (1997) 885-897
33. Kampfl A., Zhao X., Whitson J.S., Posmantur R., Dixon C.E., Yang K., Clifton G.L., and Hayes R.L. Calpain inhibitors protect against depolarization-induced neurofilament protein loss of septo-hippocampal neurons in culture. Eur. J. Neurosci. 8 (1996) 344-352
34. Katzman R., Bjorklund A., Owman C., Stenevi U., and West K.A. Evidence for regenerative axon sprouting of central catecholamine neurons in the rat mesencephalon following electrolytic lesions. Brain Res. 25 (1971) 579-596
35. Kline A.E., Massucci J.L., Marion D.W., and Dixon C.E. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J. Neurotrauma 19 (2002) 415-425
36. Kobori N., and Dash P.K. Reversal of brain injury-induced prefrontal glutamic acid decarboxylase expression and working memory deficits by D1 receptor antagonism. J. Neurosci. 26 (2006) 4236-4246
37. Kopin I.J., Bankiewicz K.S., Plunkett R.J., Jacobowitz D.M., and Oldfield E.H. Tissue implants in treatment of parkinsonian syndromes in animals and implications for use of tissue implants in humans. Adv. Neurol. 60 (1993) 707-714
38. Kordower J.H., Cochran E., Penn R.D., and Goetz C.G. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann. Neurol. 29 (1991) 405-412
39. Levin H.S. Cognitive function outcomes after traumatic brain injury. Curr. Opin. Neurol. 11 (1998) 643-646
40. Lotocki G., Alonso O.F., Frydel B., Dietrich W.D., and Keane R.W. Monoubiquitination and cellular distribution of XIAP in neurons after traumatic brain injury. J. Cereb. Blood Flow Metab. 23 (2003) 1129-1136
41. McAllister T.W., Flashman L.A., Sparling M.B., and Saykin A.J. Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment-A review. Brain Inj. 18 (2004) 331-350
42. McIntosh T.K., Yu T., and Gennarelli T.A. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J. Neurochem. 63 (1994) 1426-1433
43. Miyoshi E., Wietzikoski S., Camplessei M., Silveira R., Takahashi R.N., and Da Cunha C. Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions. Brain Res. Bull. 58 (2002) 41-47
44. Muller U., Wachter T., Barthel H., Reuter M., and von Cramon D.Y. Striatal [123I]beta-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J. Neural. Transm. 107 (2000) 303-319
45. Newcomb J.K., Kampfl A., Posmantur R.M., Zhao X., Pike B.R., Liu S.J., Clifton G.L., and Hayes R.L. Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat. J. Neurotrauma 14 (1997) 369-383
46. Onn S.P., Berger T.W., Stricker E.M., and Zigmond M.J. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res. 376 (1986) 8-19
47. Otto D., and Unsicker K. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10 (1990) 1912-1921
48. Pasinetti G.M., Osterburg H.H., Kelly A.B., Kohama S., Morgan D.G., Reinhard J.F.Jr., Stellwagen R.H., and Finch C.E. Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging. Brain Res. Mol. Brain Res. 13 (1992) 63-73
49. Pickel V.M., Joh T.H., Field P.M., Becker C.G., and Reis D.J. Cellular localization of tyrosine hydroxylase by immunohistochemistry. J. Histochem. Cytochem. 23 (1975) 1-12
50. Pifl C., and Hornykiewicz O. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochem. Int. 49 (2006) 519-524
51. Plunkett R.J., Bankiewicz K.S., Cummins A.C., Miletich R.S., Schwartz J.P., and Oldfield E.H. Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone. J. Neurosurg. 73 (1990) 918-926
52. Posmantur R., Hayes R.L., Dixon C.E., and Taft W.C. Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury. J. Neurotrauma 11 (1994) 533-545
53. Posmantur R.M., Kampfl A., Liu S.J., Heck K., Taft W.C., Clifton G.L., and Hayes R.L. Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: an immunofluorescence study. J. Neuropathol. Exp. Neurol. 55 (1996) 68-80
54. Przedborski S., Levivier M., Kostic V., Jackson-Lewis V., Dollison A., Gash D.M., Fahn S., and Cadet J.L. Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence. Brain Res. 550 (1991) 231-238
55. Ragnarsson K.T. Results of the NIH consensus conference on "rehabilitation of persons with traumatic brain injury". Restor. Neurol. Neurosci. 20 (2002) 103-108
56. Rinne J.O., Portin R., Ruottinen H., Nurmi E., Bergman J., Haaparanta M., and Solin O. Cognitive impairment and the brain dopaminergic system in Parkinson's disease: [18F]fluorodopa positron emission tomographic study. Arch. Neurol. 57 (2000) 470-475
57. Rosin D.L., Clark W.A., Goldstein M., Roth R.H., and Deutch A.Y. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience 48 (1992) 831-839
58. Sasajima H., Nakagawa K., and Yokosawa H. Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system. Eur. J. Biochem. 269 (2002) 3596-3604
59. Soriano M.A., Justicia C., Ferrer I., Rodriguez-Farre E., and Planas A.M. Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra. Neurobiol. Dis. 4 (1997) 376-385
60. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., and Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373 (1995) 335-339
61. Von Voigtlander P.F., and Moore K.E. In vivo electrically evoked release of [3H]noradrenaline from cat brain. J. Pharm. Pharmacol. 23 (1971) 381-382
62. Wagner A.K., Sokoloski J.E., Ren D., Chen X., Khan A.S., Zafonte R.D., Michael A.C., and Dixon C.E. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J. Neurochem. 95 (2005) 457-465
63. White N.M., and McDonald R.J. Multiple parallel memory systems in the brain of the rat. Neurobiol. Learn. Mem. 77 (2002) 125-184
64. Williams A.J., Dave J.R., and Tortella F.C. Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochem. Int. 49 (2006) 106-112
65. Wilson M.S., Chen X., Ma X., Ren D., Wagner A.K., Reynolds I.J., and Dixon C.E. Synaptosomal dopamine uptake in rat striatum following controlled cortical impact. J. Neurosci. Res. 80 (2005) 85-91
66. Yan H.Q., Yu J., Kline A.E., Letart P., Jenkins L.W., Marion D.W., and Dixon C.E. Evaluation of combined fibroblast growth factor-2 and moderate hypothermia therapy in traumatically brain injured rats. Brain Res. 887 (2000) 134-143
67. Yan H.Q., Kline A.E., Ma X., Hooghe-Peters E.L., Marion D.W., and Dixon C.E. Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat frontal cortex after traumatic brain injury. NeuroReport 12 (2001) 2323-2327
68. Yan H.Q., Kline A.E., Ma X., Li Y., and Dixon C.E. Traumatic brain injury reduces dopamine transporter protein expression in rat frontal cortex. NeuroReport 13 (2002) 1899-1901
69. Yao X.L., Liu J., Lee E., Ling G.S., and McCabe J.T. Cullin 5 gene expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI). Neurosci. Lett. 409 (2006) 65-69